Assessment of anti-TNF efficacy in rheumatoid arthritis -: Is three months sufficient?

被引:0
|
作者
Pocock, J. M. [1 ]
Oestoer, A. J. [1 ]
机构
[1] Addenbrookes Hosp, Dept Rheumatol, Cambridge, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:II42 / II42
页数:1
相关论文
共 50 条
  • [21] ANTI-TNF THERAPY IMPROVES HAND FUNCTION IN RHEUMATOID ARTHRITIS WITHIN 3 MONTHS
    Hull, Dobrina
    Ball, Catherine
    Abraham, Sonya
    RHEUMATOLOGY, 2012, 51 : 136 - 136
  • [22] Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
    Sergio Schwartzman
    Roy Fleischmann
    G James Morgan
    Arthritis Research & Therapy, 6
  • [23] Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)
    Sarzi-Puttini, P.
    Antivalle, M.
    Marchesoni, A.
    Favalli, E. G.
    Gorla, R.
    Filippini, M.
    Caporali, R.
    Bobbio-Pallavicini, F.
    Montecucco, C.
    Atzeni, F.
    REUMATISMO, 2008, 60 (04) : 290 - 295
  • [24] RHEUMATOID ARTHRITIS Obesity impairs efficacy of anti-TNF therapy in patients with RA
    Gonzalez-Gay, Miguel A.
    Gonzalez-Juanatey, Carlos
    NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (11) : 641 - 642
  • [25] Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
    Schwartzman, S
    Fleischmann, R
    Morgan, GJ
    ARTHRITIS RESEARCH & THERAPY, 2004, 6 (Suppl 2) : S3 - S11
  • [26] FRACTURE RISK ASSESSMENT (FRAX) IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THERAPY WITH ANTI-TNFα
    Anghel, D.
    Otlocan, L.
    Negru, M. M.
    Busuioc, E.
    Bursuc, R.
    Smedescu, V.
    Manolache, A.
    Jurcut, C.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S400 - S400
  • [27] The mechanism of action of anti-TNFα therapy in rheumatoid arthritis
    Feldmann, M
    Paleolog, E
    Taylor, P
    Brennan, F
    Maini, R
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R197 - R197
  • [28] Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
    Pauline A. van Schouwenburg
    Theo Rispens
    Gerrit Jan Wolbink
    Nature Reviews Rheumatology, 2013, 9 : 164 - 172
  • [29] Predictors of neutropaenia on anti-TNF treatment for rheumatoid arthritis
    Rajakulendran, S.
    Gadsby, K.
    Allen, D.
    O'Reilly, S.
    Deighton, C.
    RHEUMATOLOGY, 2006, 45 : I48 - I49
  • [30] Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis
    Coenen, Marieke J. H.
    Toonen, Erik J. M.
    Scheffer, Hans
    Radstake, Timothy R. D. J.
    Barrera, Pilar
    Franke, Barbara
    PHARMACOGENOMICS, 2007, 8 (07) : 761 - 773